GFM
CRL icon

GF Fund Management’s Charles River Laboratories CRL Stock Holding History

GF Fund Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$229K Hold
1,325
– – ﹤0.01% 274
2025
Q4 		$264K Sell
1,325
-23
-2% -$4.17K ﹤0.01% 266
2025
Q3 		$211K Buy
1,348
+126
+10% +$20K ﹤0.01% 290
2025
Q2 		$185K Sell
1,222
-9
-0.7% -$1.2K ﹤0.01% 324
2025
Q1 		$185K Hold
1,231
– – ﹤0.01% 324
2024
Q4 		$227K Buy
+1,231
New +$237K ﹤0.01% 279

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GF Fund Management's CRL Position: Q1 2026 in Review

GF Fund Management held its Charles River Laboratories (CRL) position steady in Q1 2026 at 1,325 shares worth $229K. The position accounts for ﹤0.01% of the portfolio, ranked #274.

GF Fund Management first reported a position in CRL in Q4 2024 and has held it in 6 quarters since. The position peaked at $264K in Q4 2025. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • GF Fund Management held 1,325 shares of Charles River Laboratories worth $229K as of Q1 2026.
  • GF Fund Management left its Charles River Laboratories share count unchanged in Q1 2026.
  • Charles River Laboratories made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #274 holding.
  • GF Fund Management first reported a position in Charles River Laboratories in Q4 2024 and has held it in 6 quarters since.
  • GF Fund Management's Charles River Laboratories position peaked at $264K in Q4 2025.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.